進行非小細胞肺癌に対するCarboplatin+weekly Paclitaxel併用化学療法の第I/II相試験 Objective. To determine the dose limiting toxicity (DLT) and maximum tolerated dose (MTD) ofcarboplatin (CBDCA) and weekly paclitaxel (PTX) for advanced no... 大橋,信之,駄賀,晴子,西野,亮平,... - 肺癌 被引...